Ceren Yapar Gümüş
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ceren Yapar Gümüş has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Ecem İpek Altınok
Ordu Üniversitesi
2 shared publications Ahmet Bayrak
Faculty of Medicine, Department of Medical Biochemistry, Ordu University
1 shared publicationAhmet Burak Gurpinar
Department of Biochemistry, School of Medicine, Ordu University, Ordu, Turkey
1 shared publication- Aybegum Kalyoncu Aycenk
Department of Paediatric Surgery, Faculty of Medicine, Ordu University, Ordu, Türkiye
1 shared publication Ecem İpek Altınok
Faculty of Medicine, Department of Pediatrics, Ordu University
1 shared publicationEmine Yurdakul Ertürk
Faculty of Medicine, Department of Pediatrics, Ordu University
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by Galenos Yayinevi in Gazi Medical Journal
Reliability of an AI-based Conversational Agent in Pediatric Dentofacial Health Counseling
Reliability of an AI-based Conversational Agent in Pediatric Dentofacial Health Counseling - Gazi Medical Journal
- 15 October 2026
- Published by Galenos Yayinevi in Gazi Medical Journal
Open AccessReliability of an AI-based Conversational Agent in Pediatric Dentofacial Health Counseling
Reliability of an AI-based Conversational Agent in Pediatric Dentofacial Health Counseling - Gazi Medical Journal
- 29 June 2026
- Published by Hitit University in Hitit Medical Journal
- Vol. 8 (2) , 259-271
Knowledge and Attitudes Toward the Cocooning Strategy for Pertussis and Influenza Among Pregnant and Early Postpartum Mothers
Objective:: Pertussis and influenza remain important causes of illness and death in early infancy. Because primary vaccination begins late in the first months of life, maternal and household immunization—known as the cocooning strategy—is essential for newborn protection.This study aimed to assess the knowledge and attitudes of pregnant and early postpartum mothers toward the cocooning strategy for pertussis and influenza, and to identify sociodemographic factors influencing awareness and vaccine acceptance.Material and Methods: A descriptive, cross-sectional study was conducted between March 2023 and March 2025 at the Department of Pediatrics, Ordu University Training and Research Hospital. A total of 382 eligible participants (pregnant or ≤6 months postpartum mothers) were included. Data were collected using a structured 28-item questionnaire evaluating sociodemographic characteristics and knowledge–attitude domains related to cocooning. Descriptive analyses, chi-square tests, logistic regression, and CHAID/CART algorithms were performed using SPSS v28, with significance set at p
- 29 June 2026
- Published by Hitit University in Hitit Medical Journal
- Vol. 8 (2) , 259-271
Knowledge and Attitudes Toward the Cocooning Strategy for Pertussis and Influenza Among Pregnant and Early Postpartum Mothers
Objective:: Pertussis and influenza remain important causes of illness and death in early infancy. Because primary vaccination begins late in the first months of life, maternal and household immunization—known as the cocooning strategy—is essential for newborn protection.This study aimed to assess the knowledge and attitudes of pregnant and early postpartum mothers toward the cocooning strategy for pertussis and influenza, and to identify sociodemographic factors influencing awareness and vaccine acceptance.Material and Methods: A descriptive, cross-sectional study was conducted between March 2023 and March 2025 at the Department of Pediatrics, Ordu University Training and Research Hospital. A total of 382 eligible participants (pregnant or ≤6 months postpartum mothers) were included. Data were collected using a structured 28-item questionnaire evaluating sociodemographic characteristics and knowledge–attitude domains related to cocooning. Descriptive analyses, chi-square tests, logistic regression, and CHAID/CART algorithms were performed using SPSS v28, with significance set at p
- Open Access
- 15 June 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1844353
Ischemia-modified albumin in children with clinically suspected acute myocarditis: diagnostic performance and incremental value beyond conventional biomarkers
Background: Pediatric acute myocarditis is challenging because presentations range from chest pain to cardiogenic shock, and no single biomarker reflects its inflammatory, ischemic, and hemodynamic components. Ischemia-modified albumin (IMA), a marker of oxidative stress-related alteration in albumin measured by the albumin cobalt-binding assay, has been investigated in ischemic and inflammatory conditions, but its role in pediatric myocarditis remains unclear. Methods: In this prospective, single-center case-control study, 47 children with clinically suspected acute myocarditis and 47 age- and sex-matched healthy controls were evaluated between 1 July 2023 and 1 July 2025. Clinically suspected acute myocarditis was defined according to pediatric guidance as at least one compatible clinical feature together with at least one supportive biomarker, electrocardiographic, or echocardiographic finding after exclusion of alternative diagnoses. IMA levels were measured using the albumin cobalt-binding method and expressed as absorbance units (ABSU). The statistical analysis included between-group comparisons, receiver operating characteristic (ROC) analyses, incremental discrimination analyses, and exploratory clinical severity analyses. Results: IMA concentrations were significantly higher in the myocarditis group than in controls [0.57 (0.55–0.63) vs. 0.55 (0.49–0.59) ABSU, p = 0.021], with a Hodges–Lehmann median difference of 0.04 ABSU (95% CI, 0.01–0.07). However, the diagnostic performance of IMA alone was modest (AUC, 0.64; 95% CI, 0.52–0.75). At the optimal cutoff of 0.53 ABSU, sensitivity was 89.36% and specificity was 38.30%. Conventional biomarkers showed stronger discrimination, including troponin I (AUC, 0.96), troponin T (AUC, 0.93), NT-proBNP (AUC, 0.88), CRP (AUC, 0.85), and CK-MB (AUC, 0.83). A base model including CK-MB, NT-proBNP, and CRP yielded an AUC of 0.92; adding IMA increased the AUC marginally to 0.93 (delta AUC, 0.01; p = 0.153). All children in the clinically suspected myocarditis group were symptomatic at presentation, and exploratory analyses showed no significant association between IMA and selected electrocardiographic or echocardiographic abnormalities or length of hospital stay. Conclusion: IMA is elevated in children with clinically suspected acute myocarditis, but its standalone diagnostic performance is limited and its added value beyond conventional biomarkers appears small. IMA may be considered an adjunctive rather than a primary diagnostic biomarker, and any putative triage role in ultra-early presentations remains hypothesis-generating.
- 15 June 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1844353
Open AccessIschemia-modified albumin in children with clinically suspected acute myocarditis: diagnostic performance and incremental value beyond conventional biomarkers
Background: Pediatric acute myocarditis is challenging because presentations range from chest pain to cardiogenic shock, and no single biomarker reflects its inflammatory, ischemic, and hemodynamic components. Ischemia-modified albumin (IMA), a marker of oxidative stress-related alteration in albumin measured by the albumin cobalt-binding assay, has been investigated in ischemic and inflammatory conditions, but its role in pediatric myocarditis remains unclear. Methods: In this prospective, single-center case-control study, 47 children with clinically suspected acute myocarditis and 47 age- and sex-matched healthy controls were evaluated between 1 July 2023 and 1 July 2025. Clinically suspected acute myocarditis was defined according to pediatric guidance as at least one compatible clinical feature together with at least one supportive biomarker, electrocardiographic, or echocardiographic finding after exclusion of alternative diagnoses. IMA levels were measured using the albumin cobalt-binding method and expressed as absorbance units (ABSU). The statistical analysis included between-group comparisons, receiver operating characteristic (ROC) analyses, incremental discrimination analyses, and exploratory clinical severity analyses. Results: IMA concentrations were significantly higher in the myocarditis group than in controls [0.57 (0.55–0.63) vs. 0.55 (0.49–0.59) ABSU, p = 0.021], with a Hodges–Lehmann median difference of 0.04 ABSU (95% CI, 0.01–0.07). However, the diagnostic performance of IMA alone was modest (AUC, 0.64; 95% CI, 0.52–0.75). At the optimal cutoff of 0.53 ABSU, sensitivity was 89.36% and specificity was 38.30%. Conventional biomarkers showed stronger discrimination, including troponin I (AUC, 0.96), troponin T (AUC, 0.93), NT-proBNP (AUC, 0.88), CRP (AUC, 0.85), and CK-MB (AUC, 0.83). A base model including CK-MB, NT-proBNP, and CRP yielded an AUC of 0.92; adding IMA increased the AUC marginally to 0.93 (delta AUC, 0.01; p = 0.153). All children in the clinically suspected myocarditis group were symptomatic at presentation, and exploratory analyses showed no significant association between IMA and selected electrocardiographic or echocardiographic abnormalities or length of hospital stay. Conclusion: IMA is elevated in children with clinically suspected acute myocarditis, but its standalone diagnostic performance is limited and its added value beyond conventional biomarkers appears small. IMA may be considered an adjunctive rather than a primary diagnostic biomarker, and any putative triage role in ultra-early presentations remains hypothesis-generating.
- Open Access
- 27 April 2026
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 32, e952489
Retrospective Study of Serum Vitamin D Levels and Metabolic-Associated Fatty Liver Disease in 222 Children and Adolescents Aged 6-18 Years With Obesity
Retrospective Study of Serum Vitamin D Levels and Metabolic-Associated Fatty Liver Disease in 222 Children and Adolescents Aged 6-18 Years With Obesity - Article abstract #952489
- 27 April 2026
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 32, e952489
Open AccessRetrospective Study of Serum Vitamin D Levels and Metabolic-Associated Fatty Liver Disease in 222 Children and Adolescents Aged 6-18 Years With Obesity
Retrospective Study of Serum Vitamin D Levels and Metabolic-Associated Fatty Liver Disease in 222 Children and Adolescents Aged 6-18 Years With Obesity - Article abstract #952489
- Open Access
- 22 July 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (15) , 1847
False Troponin Elevation in Pediatric Patients: A Long-Term Biochemical Conundrum Without Cardiac Effects
Background/Objectives: Elevated troponin levels are widely recognized as key biomarkers of myocardial injury and are frequently used in clinical decision making. However, not all instances of troponin elevation indicate true cardiac damage. In some cases, biochemical or immunological interferences may lead to false-positive results. These situations may lead to unnecessary diagnostic interventions and clinical uncertainty, ultimately impacting patient management negatively. This study aims to investigate the underlying mechanisms of false-positive troponin elevation in pediatric patients, focusing on factors such as macrotroponin formation, autoantibodies, and heterophile antibody interference. Methods: This retrospective study analyzed data from 13 pediatric patients who presented with elevated cardiac troponin levels between 2017 and 2024. Clinical evaluations included transthoracic echocardiography (TTE), electrocardiography (ECG), coronary computed tomography angiography (CTA), cardiac magnetic resonance imaging (MRI), and rheumatologic testing. Laboratory findings included measurements of cardiac troponins (cTnI and hs-cTnT) and pro-BNP levels. Results: Among 70 patients evaluated for elevated troponin levels, 13 (18.6%) were determined to have no identifiable cardiac etiology. The median age of these 13 patients was 13.0 years (range: 9–16), with 53.8% being female. The most common presenting complaints were chest pain (53.8%) and palpitations (30.8%). TTE findings were normal in 61.5% of the patients, and all patients had normal coronary CTA and cardiac MRI findings. Although initial troponin I levels were elevated in all cases, persistent positivity was observed up to 12 months. Median cTnI levels were 1.00 ng/mL (range: 0.33–7.19) at week 1 and 0.731 ng/mL (range: 0.175–4.56) at month 12. PEG precipitation testing identified macrotroponin in three patients (23.1%). No etiological explanation could be identified in 10 cases (76.9%), which were considered idiopathic. All patients had negative results for heterophile antibody and rheumatologic tests. Conclusions: When interpreting elevated troponin levels in children, biochemical interferences—especially macrotroponin—should not be overlooked. This study emphasizes the diagnostic uncertainty associated with non-cardiac troponin elevation. To better guide clinical practice and clarify false positivity rates, larger, multicenter prospective studies are needed.
- 22 July 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (15) , 1847
Open AccessFalse Troponin Elevation in Pediatric Patients: A Long-Term Biochemical Conundrum Without Cardiac Effects
Background/Objectives: Elevated troponin levels are widely recognized as key biomarkers of myocardial injury and are frequently used in clinical decision making. However, not all instances of troponin elevation indicate true cardiac damage. In some cases, biochemical or immunological interferences may lead to false-positive results. These situations may lead to unnecessary diagnostic interventions and clinical uncertainty, ultimately impacting patient management negatively. This study aims to investigate the underlying mechanisms of false-positive troponin elevation in pediatric patients, focusing on factors such as macrotroponin formation, autoantibodies, and heterophile antibody interference. Methods: This retrospective study analyzed data from 13 pediatric patients who presented with elevated cardiac troponin levels between 2017 and 2024. Clinical evaluations included transthoracic echocardiography (TTE), electrocardiography (ECG), coronary computed tomography angiography (CTA), cardiac magnetic resonance imaging (MRI), and rheumatologic testing. Laboratory findings included measurements of cardiac troponins (cTnI and hs-cTnT) and pro-BNP levels. Results: Among 70 patients evaluated for elevated troponin levels, 13 (18.6%) were determined to have no identifiable cardiac etiology. The median age of these 13 patients was 13.0 years (range: 9–16), with 53.8% being female. The most common presenting complaints were chest pain (53.8%) and palpitations (30.8%). TTE findings were normal in 61.5% of the patients, and all patients had normal coronary CTA and cardiac MRI findings. Although initial troponin I levels were elevated in all cases, persistent positivity was observed up to 12 months. Median cTnI levels were 1.00 ng/mL (range: 0.33–7.19) at week 1 and 0.731 ng/mL (range: 0.175–4.56) at month 12. PEG precipitation testing identified macrotroponin in three patients (23.1%). No etiological explanation could be identified in 10 cases (76.9%), which were considered idiopathic. All patients had negative results for heterophile antibody and rheumatologic tests. Conclusions: When interpreting elevated troponin levels in children, biochemical interferences—especially macrotroponin—should not be overlooked. This study emphasizes the diagnostic uncertainty associated with non-cardiac troponin elevation. To better guide clinical practice and clarify false positivity rates, larger, multicenter prospective studies are needed.
- Open Access
- 31 May 2025
- Published by Ordu University in MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE
- Vol. 11 (2) , 97-106
Knowledge Levels of Physicians, Nurses, and Health Technicians Working in A Children's Hospital Regarding Anaphylaxis and Adrenaline Auto-Injectors
Objective: Anaphylaxis should be recognized and treated by physicians and healthcare workers. In our study, we aimed to determine the knowledge and education levels regarding anaphylaxis and the attitudes towards adrenaline auto-injector use among doctors, nurses, and health technicians working in the Women's and Children's Annex of Ordu University Training and Research Hospital, a tertiary healthcare institution. Method: A 15-item questionnaire designed to assess demographic data, employment status, and knowledge level about anaphylaxis and its management was administered to the participants. Results: The study was completed with 136 participants, including 66 physicians, 58 nurses, and 12 technicians. It was found that 75 participants had knowledge about adrenaline auto-injectors, with 9.3% having previously issued a report on auto-injectors. Physicians showed greater knowledge in correctly administering adrenaline during anaphylaxis compared to other professional groups. Healthcare workers in the emergency department demonstrated higher levels of knowledge in adrenaline administration compared to those in other units. While no significant relationship was found between professional experience and the selection of correct treatment methods in anaphylaxis, those with longer professional lives were found to have better knowledge about adrenaline administration proportionally. Another finding from our study is that participants who received training within less than 3 years had more accurate knowledge about adrenaline administration compared to others. Conclusion: The repetition of essential training and keeping knowledge up-to-date are crucial for correct application and treatment in anaphylaxis. There is a need for organizing training sessions to increase knowledge levels and awareness, particularly among healthcare workers, including physicians.
- 31 May 2025
- Published by Ordu University in MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE
- Vol. 11 (2) , 97-106
Open AccessKnowledge Levels of Physicians, Nurses, and Health Technicians Working in A Children's Hospital Regarding Anaphylaxis and Adrenaline Auto-Injectors
Objective: Anaphylaxis should be recognized and treated by physicians and healthcare workers. In our study, we aimed to determine the knowledge and education levels regarding anaphylaxis and the attitudes towards adrenaline auto-injector use among doctors, nurses, and health technicians working in the Women's and Children's Annex of Ordu University Training and Research Hospital, a tertiary healthcare institution. Method: A 15-item questionnaire designed to assess demographic data, employment status, and knowledge level about anaphylaxis and its management was administered to the participants. Results: The study was completed with 136 participants, including 66 physicians, 58 nurses, and 12 technicians. It was found that 75 participants had knowledge about adrenaline auto-injectors, with 9.3% having previously issued a report on auto-injectors. Physicians showed greater knowledge in correctly administering adrenaline during anaphylaxis compared to other professional groups. Healthcare workers in the emergency department demonstrated higher levels of knowledge in adrenaline administration compared to those in other units. While no significant relationship was found between professional experience and the selection of correct treatment methods in anaphylaxis, those with longer professional lives were found to have better knowledge about adrenaline administration proportionally. Another finding from our study is that participants who received training within less than 3 years had more accurate knowledge about adrenaline administration compared to others. Conclusion: The repetition of essential training and keeping knowledge up-to-date are crucial for correct application and treatment in anaphylaxis. There is a need for organizing training sessions to increase knowledge levels and awareness, particularly among healthcare workers, including physicians.
- Open Access
- 24 December 2024
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 26 (3) , 284-288
YOUTUBE VIDEOS AS A SOURCE OF INFORMATION FOR FAMILIES ON 'BASIC NEWBORN CARE'
Objective: Information obtained from the internet provides speed and convenience, but it can also lead to misinformation and confusion. YouTube is one of the most widely used video websites in Turkey. Therefore, This study sought to assess the information quality available in YouTube videos on neonatal care. Material and Methods: English words "newborn care" and "neonatal care" were used as search terms on the official YouTube website (http://www.youtube.com). The first 200 videos were downloaded and videos that did not comply with the evaluation criteria were deactivated. Video uploaders were categorized as doctors, nurses, health professionals other than doctors and nurses, television programs/news agencies, health and medical information websites, and others. Videos were analyzed by two independent reviewers. Videos were evaluated according to the modified DISCERN, JAMA, and Global Quality Score. Results: A total of 29 videos were included in the study. Two of the videos (6.8%) were obtained from non-health websites. Others were created by health organizations and or healthcare workers. The mean modified DISCERN score of the videos was 28±6. Of these videos, 11 (38%) were rated as very good, 10(34%) as good, 5 (17%) as moderate and 3 (10%) as non- qualified. The mean JAMA score was 1.0±0.9. Conclusion: Videos uploaded mostly by health care workers and health organizations and not including advertisements were found to be informative enough by 90%. Choosing the uploaders carefully to access reliable health information is of utmost importance for supplying qualified information.
- 24 December 2024
- Published by Kirikkale Universitesi Tip Fakultesi Dergisi in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
- Vol. 26 (3) , 284-288
Open AccessYOUTUBE VIDEOS AS A SOURCE OF INFORMATION FOR FAMILIES ON 'BASIC NEWBORN CARE'
Objective: Information obtained from the internet provides speed and convenience, but it can also lead to misinformation and confusion. YouTube is one of the most widely used video websites in Turkey. Therefore, This study sought to assess the information quality available in YouTube videos on neonatal care. Material and Methods: English words "newborn care" and "neonatal care" were used as search terms on the official YouTube website (http://www.youtube.com). The first 200 videos were downloaded and videos that did not comply with the evaluation criteria were deactivated. Video uploaders were categorized as doctors, nurses, health professionals other than doctors and nurses, television programs/news agencies, health and medical information websites, and others. Videos were analyzed by two independent reviewers. Videos were evaluated according to the modified DISCERN, JAMA, and Global Quality Score. Results: A total of 29 videos were included in the study. Two of the videos (6.8%) were obtained from non-health websites. Others were created by health organizations and or healthcare workers. The mean modified DISCERN score of the videos was 28±6. Of these videos, 11 (38%) were rated as very good, 10(34%) as good, 5 (17%) as moderate and 3 (10%) as non- qualified. The mean JAMA score was 1.0±0.9. Conclusion: Videos uploaded mostly by health care workers and health organizations and not including advertisements were found to be informative enough by 90%. Choosing the uploaders carefully to access reliable health information is of utmost importance for supplying qualified information.
- Open Access
- 23 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Effect of castor oil on esophageal stricture in rats and expression of ST-2, neopterin proteins in corrosive burn model
Corrosive esophageal burn (CEB) is a disease with high mortality and morbidity rates. The aim of this study was to determine the efficacy of castor oil, in preventing stricture development at the experimental CEB model. In addition to studying standard histopathological damage data, neopterin, IL-33, and ST-2 proteins were also studied for the first time. Fifty Wistar-Albino rats were divided into randomized 5 groups. [Sham group (G1) (n:10), Control group (G2) (n:10), Early Stage Topical Application group (G3)(n:10), Late Stage Topical Application group (G4) (n:10), Oral Application group (G5) (n:10)]. Weight measurement, esophageal length, histopathological damage score (HDS) and total stenosis score (TSS), tissue caspase-3 and VEGF staining, tissue hydroxyproline (HYP), blood TNF-alpha, IL-6, IL-33, Neopterin, and ST-2 levels were measured. In the castor oil application groups, weight gain was observed, the acute phase reaction decreased, submucosal/tunica muscularis fibrosis (TMF) and muscularis mucosal damage (MMD) were reduced, and TSS and HDS decreased. While no significant difference was detected in the ST-2 protein, which was used for the first time in this study model, a significant increase in neopterin protein was observed in the application groups. Results indicate the nutritional contribution of castor oil, as well as its tissue healing and esophageal stricture-preventing efficacy at histopathological and immune-histochemical levels.
- 23 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Open AccessEffect of castor oil on esophageal stricture in rats and expression of ST-2, neopterin proteins in corrosive burn model
Corrosive esophageal burn (CEB) is a disease with high mortality and morbidity rates. The aim of this study was to determine the efficacy of castor oil, in preventing stricture development at the experimental CEB model. In addition to studying standard histopathological damage data, neopterin, IL-33, and ST-2 proteins were also studied for the first time. Fifty Wistar-Albino rats were divided into randomized 5 groups. [Sham group (G1) (n:10), Control group (G2) (n:10), Early Stage Topical Application group (G3)(n:10), Late Stage Topical Application group (G4) (n:10), Oral Application group (G5) (n:10)]. Weight measurement, esophageal length, histopathological damage score (HDS) and total stenosis score (TSS), tissue caspase-3 and VEGF staining, tissue hydroxyproline (HYP), blood TNF-alpha, IL-6, IL-33, Neopterin, and ST-2 levels were measured. In the castor oil application groups, weight gain was observed, the acute phase reaction decreased, submucosal/tunica muscularis fibrosis (TMF) and muscularis mucosal damage (MMD) were reduced, and TSS and HDS decreased. While no significant difference was detected in the ST-2 protein, which was used for the first time in this study model, a significant increase in neopterin protein was observed in the application groups. Results indicate the nutritional contribution of castor oil, as well as its tissue healing and esophageal stricture-preventing efficacy at histopathological and immune-histochemical levels.
- 1 January 2024
- Published by Kare Publishing in Zeynep Kamil Medical Journal
- Vol. 55 (3) , 168-174
Investigation of factors by real-time polymerase chain reaction analysis in hospitalized patients with acute lower respiratory tract infections
- 1 January 2024
- Published by Kare Publishing in Zeynep Kamil Medical Journal
- Vol. 55 (3) , 168-174
Investigation of factors by real-time polymerase chain reaction analysis in hospitalized patients with acute lower respiratory tract infections